M
Metagenomi Therapeutics, Inc. (MGX)
NMS – Real Time Price. Currency in USD
1.35
0.00 (0.00%)
At close: May 12, 2026, 4:00 PM EDT
1.41
+0.06 (4.44%)
After-hours: May 12, 2026, 7:25 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.35
0.00 (0.00%)
At close: May 12, 2026, 4:00 PM EDT
1.41
+0.06 (4.44%)
After-hours: May 12, 2026, 7:25 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $41.7M significantly exceed its total debt $40.7M, ensuring strong financial flexibility
Total current assets $165.5M exceed Total current liabilities $22.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.3) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$23.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.22 | 6.05 | 10 | |
| Quick ratio | 7.22 | 5.63 | 10 | |
| Debt to Equity | 0.26 | 0.30 | 8.0 | |
| Debt to Assets | 0.17 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 17M | 45M | 52M | 25M | 25M |
| Gross Profit | 15M | 41M | 47M | 20M | 20M |
| Operating Income | -45M | -78M | -89M | -96M | -96M |
| Net Income | -44M | -68M | -78M | -88M | -88M |
| EBITDA | -43M | -74M | -83M | -91M | -91M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 43.03 | 18.62 | 9.5 |
| Next quarter | -30.66 | -2.56 | 1.0 |
| Current year | -6.44 | 10.34 | 4.0 |
| Next year | -3.82 | 9.98 | 3.5 |
| Weighted average score | 4.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -54.82 | -10.46 | -7.26 | -10.79 | 1.0 |
| Y/Y | -59.31 | 3.72 | -59.45 | 11.2 | 3.3 |
| 3y average | 41.76 | -27.81 | 44.12 | -244.45 | 5.5 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |